Outsourcing

Craig A. Steger is SVP–Life Sciences at Outcome Capital LLC, 99 High St., Suite 2900, Boston MA.

Thomas J. Joyce is Associate at Outcome Capital LLC, 99 High St., Suite 2900, Boston MA.

Oded Ben-Joseph, PhD, is Managing Director, at Outcome Capital LLC, 99 High St., Suite 2900, Boston MA.

Articles

The CRO market will see greater consolidation by both financial buyers looking to consolidate smaller players and larger CRO players wanting to expand into value-added specialty service areas.

Pharma Services Sector Poised for Continued Growth and Consolidation

The companies have entered into an agreement to develop processes for a novel immunotherapy protein.

SelectImmune and Lonza to Develop Immunotherapeutic Drug Candidate

Editor of Pharmaceutical Technology Europe

Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.

Developing a Method for Success through Partnerships

Agnes Shanley is senior editor of Pharmaceutical Technology.

Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines. 


COVID-19: Shoring Up the Drug Delivery Infrastructure

Contract service organizations can offer biopharma companies early insight into dangers that may hinder a drug’s later development.

Seeking Early Answers to Formulation Questions

Alcami Biologics formed to meet market demands for biological drug development services.

Alcami Announces Biologics Enterprise

The merged companies will provide histopathology services in the research and pre-clinical therapeutics markets. 

Histo-Scientific Research Laboratories and Vet Path Services Merge

ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.

ADC Bio Secures Additional Equity Round Investment

Formulation issues cause significant drug project delays and project failures, according to a 2018 survey conducted by Informa Pharma Intelligence, Rentschler Biopharma, and LEUKOCARE.

Survey Predicts Drug Product Formulation Recognition and Increasing Budgets

The company says the new equipment will reduce sample turnaround times and increase variant detection quality and accuracy.

Contract Services, Formulation and Drug Delivery